SCHEMBL9787294

SCHEMBL9787294

CCOc1cncc(C(=O)c2[nH]c(=S)[nH]c2C)c1

nearest known ligand 0.39

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 3/20 0.39
▸ NPSR1 Q6W5P4 1/20 0.39
▸ ALDH1A1 P00352 1/20 0.37
▸ HPGD P15428 1/20 0.37
▸ CYP2C9 P11712 1/20 0.36
▸ CYP2C19 P33261 1/20 0.36
▸ LMNA P02545 2/20 0.34
▸ TSHR P16473 1/20 0.34
▸ GRM5 P41594 1/20 0.34
▸ CCNC P24863 1/20 0.34
▸ CDK8 P49336 1/20 0.34
▸ POLB P06746 1/20 0.34
▸ RIPK2 O43353 1/20 0.33
▸ CHRNB2 P17787 1/20 0.33
▸ CHRNA4 P43681 1/20 0.33
▸ HTT P42858 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7439917 0.86 PDE4A (0.43) KMT2ANPSR1HPGDCYP2C9CYP2C19
SCHEMBL3862907 0.72 CYP2C9 (0.66) KMT2AALDH1A1CYP2C9CYP2C19LMNA
SCHEMBL14260770 0.72 CYP2C9 (0.60) KMT2AALDH1A1CYP2C9CYP2C19LMNA
SCHEMBL9448534 0.70 PARP10 (0.56) TSHR
SCHEMBL31530613 0.68 KDM4E (0.58) KMT2AALDH1A1LMNATSHRHTT
SCHEMBL7430668 0.67 NPSR1 (0.47) KMT2ANPSR1ALDH1A1HPGDCYP2C9
SCHEMBL9787345 0.66 DRD3 (0.38) KMT2AALDH1A1HPGDCYP2C9CYP2C19
SCHEMBL7438756 0.66 ALDH1A1 (0.45) KMT2ANPSR1ALDH1A1HPGDCYP2C9
SCHEMBL3819558 0.65 CYP11B1 (0.51) CHRNB2CHRNA4
SCHEMBL276284 0.65 CYP1A2 (0.56) KMT2ANPSR1ALDH1A1HPGDCYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4999365-A Preventing damage which occurs to heart tissue when oxygen is reintroduced after a heart attack MERRELL DOW PHARMACEUTICALS INC. (US) 1991-03-12 — — US disclosed
EP-0284925-A2 Use of imidazol-2-thiones for the preparation of a medicament for reducing myocardial stunning MERRELL DOW PHARMACEUTICALS INC. (US) 1988-10-05 — — EP disclosed
Send feedback